Decentralized Science Project Aubrai Launches on Base to Address Funding Gaps
Aubrai, a decentralized science (DeSci) initiative launched on Base, integrates longevity research with blockchain technology. Key points include:
- Aubrai offers the AUBRAI token, enabling holders to participate in funding decisions and share revenues from research outputs.
- Created by VitaDAO and Bio Protocol alongside Aubrey de Grey’s LEV Foundation, it aims to address funding gaps in longevity research.
- De Grey advocates for DAOs and alternative funding mechanisms to overcome reliance on traditional capital sources.
- The platform utilizes unpublished lab data to generate innovative hypotheses in longevity science, enhancing research efficiency.
- Successful experiments will result in IP-tokens licensed to biotech firms, with profits recycled back to contributors.
- Aubrai is currently applied in the Robust Mouse Rejuvenation study, optimizing methodologies and identifying potential issues early.
- Despite its potential, DeSci faces regulatory challenges and skepticism from established pharmaceutical companies.
If successful, Aubrai could redefine funding models in biomedical innovation, accelerating advancements in longevity therapies.